Alyacen 7/7/7 Tablets
Glenmark is recalling Alyacen 7/7/7 tablets due to out-of-specification results for total impurities.
Contact your healthcare provider or pharmacist if you have questions or concerns regarding your medication. Do not stop taking your medication without consulting a medical professional.
Why it was recalled
Glenmark Pharmaceuticals is recalling Alyacen 7/7/7 (Norethindrone and Ethinyl Estradiol) tablets due to out-of-specification results for total impurities. The affected product consists of 3-blister card packs, each containing a 28-day regimen.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Alyacen 7/7/7, Norethindrone and Ethinyl Estradiol Tablets USP, 0.5mg/0.035mg, 0.75mg/0.035mg, 1 mg/0.0.35mg, 3 Blister Cards each containing 28 tablets, 28 day regimen, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd., Colvale-Bardez, Goa 403 513, India, Manufactured for: Glenmark Pharmaceuticals Inc., Mahwah, NJ 07430, NDC 68462-556-29
- UPC
- 20240411, 20250252
- Recall #
- D-0588-2026
Where it was sold
Distributed nationwide.
Official source
Editorial summary by Recall Canary · last updated 2026-06-13 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification